Snowden Capital Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.11M Buy
2,856
+1
+0% +$389 0.03% 481
2025
Q1
$1.24M Buy
2,855
+691
+32% +$301K 0.04% 432
2024
Q4
$798K Sell
2,164
-533
-20% -$197K 0.02% 585
2024
Q3
$1.4M Sell
2,697
-7
-0.3% -$3.64K 0.04% 426
2024
Q2
$1.46M Sell
2,704
-92
-3% -$49.8K 0.04% 402
2024
Q1
$1.45M Buy
2,796
+755
+37% +$391K 0.05% 407
2023
Q4
$962K Sell
2,041
-242
-11% -$114K 0.04% 452
2023
Q3
$994K Sell
2,283
-252
-10% -$110K 0.04% 421
2023
Q2
$1.13M Buy
2,535
+129
+5% +$57.3K 0.04% 426
2023
Q1
$1.11M Sell
2,406
-14,738
-86% -$6.78M 0.04% 434
2022
Q4
$8.79M Sell
17,144
-688
-4% -$353K 0.37% 47
2022
Q3
$8.1M Sell
17,832
-599
-3% -$272K 0.37% 46
2022
Q2
$8.89M Sell
18,431
-471
-2% -$227K 0.4% 43
2022
Q1
$9.29M Buy
18,902
+17,410
+1,167% +$8.55M 0.37% 53
2021
Q4
$691K Sell
1,492
-1,723
-54% -$798K 0.04% 398
2021
Q3
$1.2M Buy
3,215
+78
+2% +$29.1K 0.06% 335
2021
Q2
$1.2M Sell
3,137
-668
-18% -$255K 0.06% 341
2021
Q1
$1.37M Buy
3,805
+2,281
+150% +$819K 0.08% 292
2020
Q4
$489K Sell
1,524
-153
-9% -$49.1K 0.03% 446
2020
Q3
$450K Sell
1,677
-2
-0.1% -$537 0.04% 407
2020
Q2
$442K Buy
+1,679
New +$442K 0.04% 398
2018
Q4
Sell
-756
Closed -$207K 472
2018
Q3
$207K Buy
+756
New +$207K 0.02% 469